𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A prospective, multicentre clinical trial comparing cisplatin plus gemcitabine with cisplatin plus etoposide in patients with locally advanced and metastatic non-small cell lung cancer

✍ Scribed by Tuncay GOKSEL; Osman Nuri HATIPOGLU; Can OZTURK; Metin GORGUNER; Murat KIYIK; Ugur YILMAZ; Asuman GUZELANT; Sezai TASBAKAN; Erhan TABAKOGLU; Hikmet FIRAT; Umit TUTAR; Sadettin CIKRIKICIOGLU; Atila AKKOCLU; Serdar SOYER; Ebru CAKIR; Oya ITIL; Salahattin SANAL

Book ID
108964350
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
86 KB
Volume
10
Category
Article
ISSN
1323-7799

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter, randomized, Phase II stud
A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma
✍ Filippo De Marinis; Fabrizio Nelli; Marco Lombardo; Francesco Ferraú; Santi Barb 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to evaluate the activity and toxicity of combined cisplatin, etoposide, and gemcitabine (PEG) and combined cisplatin plus gemcitabine (PG) in previously untreated patients with extensive‐stage and poor‐prognosis limited‐stage small‐cell lun